$-0.04
(Market cap
$1 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
--
P/B Ratio
19.1
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$-28 Mln
-
ROE
-13.7 %
-
ROCE
-- %
-
Industry P/E
--
-
EV/EBITDA
0.1
-
Debt to Equity
0
-
Book Value
$--
-
EPS
$-0.9
-
Face value
--
-
Shares outstanding
2,947,660
6 Years Aggregate
CFO
$-282.12 Mln
EBITDA
$-299.80 Mln
Net Profit
$-335.27 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Axcella Health (AXLA)
| -95.1 | -68.9 | -96.2 | -94.9 | -85.5 | -- | -- |
|
BSE Sensex*
| -8.7 | 3.6 | -7.5 | -4.2 | 8.2 | 9.5 | 11.9 |
|
Company
|
2023
|
2022
|
2021
|
2020
|
|---|---|---|---|---|
|
Axcella Health (AXLA)
| -95.1 | -84.3 | -59.7 | 29.4 |
|
BSE Sensex
| 18.7 | 4.4 | 22.0 | 15.8 |
|
BSE Sensex
| 18.7 | 4.4 | 22.0 | 15.8 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Axcella Health (AXLA)
|
0.4 | 1.2 | 0.0 | -50.0 | -- | -- | -- | 19.1 |
| 78.0 | 11,082.2 | 1,091.0 | 202.3 | 31.6 | 31.3 | 49.5 | 18.5 | |
| 46.2 | 12,241.0 | 2,320.1 | 782.6 | 39.0 | 35.5 | 16.1 | 5.2 | |
| 92.3 | 12,229.9 | 982.0 | -416.3 | -42.1 | 348.4 | -- | 55.7 | |
| 65.2 | 7,860.8 | 1,396.6 | 316.9 | 59.8 | 153.6 | 25.9 | 156.7 | |
| 296.7 | 8,519.4 | 389.1 | 204.8 | 41.5 | 18.9 | 38.7 | 6.6 | |
| 534.9 | 12,443.8 | 958.4 | -288.3 | -27.8 | -42.5 | -- | 19.8 | |
| 428.7 | 12,189.0 | 2,678.3 | 460.4 | 21.1 | 103.2 | 26.9 | 19.9 | |
| 102.4 | 8,234.3 | 0.0 | -425.4 | -- | -36.7 | -- | 6.5 | |
| 333.3 | 9,422.8 | 0.0 | -303.3 | -- | -45.8 | -- | 10.7 |
Shareholding Pattern
View DetailsAbout Axcella Health (AXLA)
Axcella Health Inc. operates as a clinical-stage biotechnology company in the United States. The company treats complex diseases using endogenous metabolic modulators. Its product pipeline includes AXA1125 that is in Phase 2a clinical trial for long... COVID therapy for patients, as well as Phase 2b clinical trial for treating non-alcoholic steatohepatitis; and AXA1665, which is in Phase 2 clinical trial for the reduction in risk of overt hepatic encephalopathy recurrence. The company was formerly known as Newco LS16, Inc. and changed its name to Axcella Health Inc. in June 2016. Axcella Health Inc. was incorporated in 2008 and is based in Cambridge, Massachusetts. Read more
-
Pres, CEO & Director
Mr. William R. Hinshaw Jr.
-
Pres, CEO & Director
Mr. William R. Hinshaw Jr.
-
Headquarters
Cambridge, MA
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Axcella Health (AXLA)
What is the current share price of Axcella Health Inc (AXLA) Today?
The share price of Axcella Health Inc (AXLA) is $0.40 (NASDAQ) as of 29-Dec-2023 16:00 EDT. Axcella Health Inc (AXLA) has given a return of -85.51% in the last 3 years.
What is the current PB & PE ratio of Axcella Health Inc (AXLA)?
Since, TTM earnings of Axcella Health Inc (AXLA) is negative, P/E ratio is not available.
The P/B ratio of Axcella Health Inc (AXLA) is 19.10 times as on 29-Dec-2023, a 329 premium to its peers’ median range of 4.45 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2022
|
-0.22
|
4.28
|
|
2021
|
-1.21
|
3.69
|
|
2020
|
-3.31
|
2.58
|
|
2019
|
-1.55
|
1.54
|
|
2018
|
--
|
--
|
What is the 52 Week High and Low of Axcella Health Inc (AXLA)?
The 52-week high and low of Axcella Health Inc (AXLA) are Rs -- and Rs -- as of 08-May-2026.
What is the market cap of Axcella Health Inc (AXLA)?
Axcella Health Inc (AXLA) has a market capitalisation of $ 1 Mln as on 29-Dec-2023. As per SEBI classification, it is a company.
Should I invest in Axcella Health Inc (AXLA)?
Before investing in Axcella Health Inc (AXLA), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.